Company Name: Versartis, Inc.
Versartis, Inc. is a biopharmaceutical company. The company is engaged in the development of long-acting therapeutic proteins designed to treat endocrine disorders. The company’s initial developmental product candidate is designed to treat growth hormone deficiency (GHD).
Ticker Symbol: VSAR (NASDAQ)
Company Website: www.versartis.com
Social Media: Versartis LinkedIn
Headquarters: Menlo Park, California